Key facts
- NVCR - NovoCure Ltd has 25 insiders with reported activity on this page.
- Net insider value flow over the last year: -$1,750,460.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 25 Insiders of NovoCure Ltd
- Symbol
- NVCR on Nasdaq
- Location
- St. Helier
Change
- Buy value: $1,228,659; sell value: $2,979,118.
- Net share flow: -109,911.
Research use
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$1,750,460.
Buys
$1,228,659
Shares: 101,550
Insiders: 2
Sells
$2,979,119
Shares: 211,461
Insiders: 15
Net
-$1,750,460
Shares: -109,911
Insiders: -13
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 152,053 | $0 | $2,021,294 | -$2,021,294 |
| 3-6 | 0 | 21,220 | $0 | $291,257 | -$291,257 |
| 6-9 | 81,550 | 0 | $996,859 | $0 | +$996,859 |
| 9-12 | 20,000 | 38,188 | $231,800 | $666,568 | -$434,768 |
NovoCure Ltd executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Ashley Cordova | Former Chief Executive Officer | $9,371,599 | +$996,859 | +12% | Mixed | 04 Mar 2026 |
| Frank X. Leonard | Chief Executive Officer | $8,052,580 | -$833,601 | -9.4% | Mixed | 03 Mar 2026 |
| Wilhelmus Cm Groenhuysen | Chief Operating Officer | $5,255,930 | Mixed | 28 Jun 2024 | ||
| Uri Weinberg | Chf Medical and Innovation Ofr | $5,037,536 | -$232,178 | -4.4% | Mixed | 03 Mar 2026 |
| Asaf Danziger | Director | $4,577,049 | Mixed | 31 Dec 2025 | ||
| Barak Ben Arye | General Counsel | $4,520,403 | Mixed | 03 Mar 2026 | ||
| William F. Doyle | Executive Chairman, Director | $4,409,977 | -$932,883 | -17% | Filing P/S | 03 Mar 2026 |
| Michal Nath Puri | Chief Human Resources Officer | $4,161,136 | -$34,325 | -0.82% | Mixed | 03 Mar 2026 |
| Christoph Brackmann | Chief Financial Officer | $3,915,252 | +$146,486 | +3.9% | Mixed | 03 Mar 2026 |
| Nicolas Leupin | Former Chief Medical Officer | $2,852,643 | -$28,696 | -1% | Mixed | 04 Mar 2026 |
| Mukund Paravasthu | Chief Operating Officer | $2,485,654 | -$693,966 | -22% | Mixed | 03 Mar 2026 |
| Moshe Giladi | Chief Science Officer | $2,411,503 | Mixed | 27 Feb 2024 | ||
| W. Anthony Vernon | Director | $2,288,094 | -$17,329 | -0.75% | Mixed | 28 Apr 2026 |
| Gabriel Leung | Director | $1,760,902 | -$17,297 | -0.97% | Mixed | 04 Jun 2025 |
| Shah Pritesh | Chief Growth Officer | $1,575,064 | Filing P/S | 07 Nov 2023 | ||
| Todd Christopher Longsworth | General Counsel | $860,119 | Mixed | 08 Mar 2022 | ||
| William Patrick Burke | Chief Human Resources Officer | $840,555 | Mixed | 30 Jun 2023 | ||
| David Hung | Director | $521,742 | -$17,280 | -3.2% | Mixed | 04 Jun 2025 |
| Martin J. Madden | Director | $422,591 | -$17,176 | -3.9% | Mixed | 04 Jun 2025 |
| Timothy J. Scannell | Director | $410,865 | -$17,299 | -4% | Mixed | 04 Jun 2025 |
| Jeryl L. Hilleman | Director | $403,200 | -$17,247 | -4.1% | Mixed | 04 Jun 2025 |
| Ely Benaim | Chief Medical Officer | $363,941 | Mixed | 06 Jan 2023 | ||
| Kristin Stafford | Director | $357,661 | -$17,259 | -4.6% | Mixed | 04 Jun 2025 |
| Allyson J. Ocean | Director | $357,661 | -$17,269 | -4.6% | Mixed | 04 Jun 2025 |
| Sherilyn S. McCoy | Director | $17,179 | Mixed | 09 Jun 2021 |
Top shareholders of NovoCure Ltd (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Soleus Capital Master Fund, L.P. |
13D/G
|
— |
9.1%
|
10,492,391
|
$110,694,725 | +$20,696,209 | 31 Mar 2026 | |
| BlackRock, Inc. |
13D/G
13F
|
Company |
8.3%
|
9,083,620
|
$168,501,151 | $0 | 31 Mar 2025 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13D/G
13F
|
Vanguard Portfolio Management · Company |
5.6%
|
6,339,994
|
$69,105,935 | $0 | 31 Mar 2026 | |
| Capital World Investors |
13D/G
|
— |
1.8%
|
2,000,000
|
$25,840,000 | -$56,626,396 | 30 Sep 2025 | |
| Asaf Danziger |
3/4/5
|
Director |
0.36%
|
416,474
|
$4,577,049 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
15%
|
17,069,149
|
$186,053,728 | — | 31 Mar 2026 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
9.1%
|
10,492,391
|
$114,367,062 | — | 31 Mar 2026 | |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
|
Company |
4.1%
|
4,682,064
|
$51,034,498 | — | 31 Mar 2026 | |
| MORGAN STANLEY |
13F
|
Company |
3.9%
|
4,541,526
|
$49,502,634 | — | 31 Mar 2026 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
2.6%
|
2,951,237
|
$32,168,485 | — | 31 Mar 2026 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
2,561,817
|
$27,923,805 | — | 31 Mar 2026 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
2,511,707
|
$27,382,941 | — | 31 Mar 2026 | |
| Quantinno Capital Management LP |
13F
|
Company |
2.2%
|
2,487,376
|
$27,112,398 | — | 31 Mar 2026 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.3%
|
1,551,554
|
$16,911,939 | — | 31 Mar 2026 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.2%
|
1,361,391
|
$14,839,162 | — | 31 Mar 2026 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.2%
|
1,331,492
|
$14,513,263 | — | 31 Mar 2026 | |
| Palo Alto Investors LP |
13F
|
Company |
1.1%
|
1,280,439
|
$13,956,785 | — | 31 Mar 2026 | |
| SG Americas Securities, LLC |
13F
|
Company |
1.1%
|
1,245,541
|
$13,576,000 | — | 31 Mar 2026 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
0.93%
|
1,071,584
|
$11,680,266 | — | 31 Mar 2026 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.88%
|
1,019,969
|
$10,566,879 | — | 31 Mar 2026 | |
| Nuveen, LLC |
13F
|
Company |
0.85%
|
982,353
|
$10,707,648 | — | 31 Mar 2026 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.84%
|
971,784
|
$10,592,000 | — | 31 Mar 2026 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.83%
|
960,056
|
$10,461,659 | — | 31 Mar 2026 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.81%
|
930,166
|
$9,636,519 | — | 31 Mar 2026 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
0.8%
|
927,382
|
$10,109,000 | — | 31 Mar 2026 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.77%
|
883,578
|
$9,631,000 | — | 31 Mar 2026 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.73%
|
837,494
|
$9,128,685 | — | 31 Mar 2026 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
0.68%
|
784,805
|
$8,554,375 | — | 31 Mar 2026 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.65%
|
745,435
|
$8,125,236 | — | 31 Mar 2026 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.63%
|
726,400
|
$7,917,760 | — | 31 Mar 2026 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.62%
|
716,539
|
$7,810,275 | — | 31 Mar 2026 | |
| VANGUARD FIDUCIARY TRUST CO |
13F
|
Company |
0.62%
|
712,769
|
$7,769,182 | — | 31 Mar 2026 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.61%
|
708,293
|
$7,720,394 | — | 31 Mar 2026 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.56%
|
647,062
|
$7,052,976 | — | 31 Mar 2026 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.54%
|
625,797
|
$6,821,000 | — | 31 Mar 2026 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.44%
|
509,642
|
$5,555,098 | — | 31 Mar 2026 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.39%
|
452,370
|
$4,930,833 | — | 31 Mar 2026 | |
| Jump Financial, LLC |
13F
|
Company |
0.32%
|
368,377
|
$4,015,310 | — | 31 Mar 2026 | |
| Legal & General Group Plc |
13F
|
Company |
0.29%
|
330,937
|
$3,607,213 | — | 31 Mar 2026 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.27%
|
314,734
|
$3,430,601 | — | 31 Mar 2026 | |
| BARCLAYS PLC |
13F
|
Company |
0.26%
|
297,416
|
$3,241,837 | — | 31 Mar 2026 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.25%
|
289,296
|
$3,153,326 | — | 31 Mar 2026 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.24%
|
281,471
|
$3,068,036 | — | 31 Mar 2026 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.24%
|
274,932
|
$2,892,285 | — | 31 Mar 2026 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.23%
|
262,147
|
$2,852,000 | — | 31 Mar 2026 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.22%
|
250,000
|
$2,725,000 | — | 31 Mar 2026 | |
| UBS Group AG |
13F
|
Company |
0.21%
|
245,817
|
$2,679,406 | — | 31 Mar 2026 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.2%
|
228,269
|
$2,488,134 | — | 31 Mar 2026 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.19%
|
222,809
|
$2,428,618 | — | 31 Mar 2026 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.19%
|
218,300
|
$2,379,470 | — | 31 Mar 2026 |
Recent Insider Transactions by Companies or Individuals for NovoCure Ltd
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| W. Anthony Vernon | NVCR | Ordinary Shares | Options Exercise | 12% | 21,500 | 200,602 | 28 Apr 2026 | Direct | ||
| W. Anthony Vernon | NVCR | Stock Option (Right to Buy) | Options Exercise | -100% | -21,500 | 0 | 28 Apr 2026 | Direct | ||
| Mukund Paravasthu | NVCR | Ordinary Shares | Sale | -37.3% | $595,670 | $13.77 | -43,246 | 72,832 | 05 Mar 2026 | Direct |
| Nicolas Leupin | NVCR | Ordinary Shares | Sale | -1.06% | $14,636 | $13.31 | -1,100 | 102,979 | 04 Mar 2026 | Direct |
| Ashley Cordova | NVCR | Ordinary Shares | Tax liability | -4.01% | -17,638 | 422,570 | 04 Mar 2026 | Direct | ||
| Uri Weinberg | NVCR | Ordinary Shares | Sale | -2.34% | $85,314 | $13.31 | -6,412 | 267,190 | 04 Mar 2026 | Direct |
| Christoph Brackmann | NVCR | Ordinary Shares | Sale | -3.39% | $85,314 | $13.31 | -6,412 | 182,842 | 04 Mar 2026 | Direct |
| Frank X. Leonard | NVCR | Ordinary Shares | Sale | -1.12% | $74,603 | $13.31 | -5,607 | 493,793 | 04 Mar 2026 | Direct |
| Mukund Paravasthu | NVCR | Ordinary Shares | Sale | -4.43% | $71,543 | $13.31 | -5,377 | 116,078 | 04 Mar 2026 | Direct |
| Michal Nath Puri | NVCR | Ordinary Shares | Sale | -0.54% | $14,636 | $13.31 | -1,100 | 201,322 | 04 Mar 2026 | Direct |
| Barak Ben Arye | NVCR | Ordinary Shares | Award | 26.1% | 50,125 | 242,453 | 03 Mar 2026 | Direct | ||
| Barak Ben Arye | NVCR | Stock Option (Right to Buy) | Award | 73,340 | 73,340 | 03 Mar 2026 | Direct | |||
| Uri Weinberg | NVCR | Ordinary Shares | Award | 22.4% | 50,125 | 273,602 | 03 Mar 2026 | Direct | ||
| Uri Weinberg | NVCR | Stock Option (Right to Buy) | Award | 73,340 | 73,340 | 03 Mar 2026 | Direct | |||
| Christoph Brackmann | NVCR | Ordinary Shares | Award | 41.1% | 55,137 | 189,254 | 03 Mar 2026 | Direct | ||
| Christoph Brackmann | NVCR | Stock Option (Right to Buy) | Award | 80,674 | 80,674 | 03 Mar 2026 | Direct | |||
| Frank X. Leonard | NVCR | Ordinary Shares | Award | 42.9% | 150,000 | 499,400 | 03 Mar 2026 | Direct | ||
| Frank X. Leonard | NVCR | Stock Option (Right to Buy) | Award | 216,388 | 216,388 | 03 Mar 2026 | Direct | |||
| Mukund Paravasthu | NVCR | Ordinary Shares | Award | 59.1% | 45,112 | 121,455 | 03 Mar 2026 | Direct | ||
| Mukund Paravasthu | NVCR | Stock Option (Right to Buy) | Award | 66,006 | 66,006 | 03 Mar 2026 | Direct | |||
| Michal Nath Puri | NVCR | Ordinary Shares | Award | 24.7% | 40,100 | 202,422 | 03 Mar 2026 | Direct | ||
| Michal Nath Puri | NVCR | Stock Option (Right to Buy) | Award | 58,672 | 58,672 | 03 Mar 2026 | Direct | |||
| William F. Doyle | NVCR | Ordinary Shares | Sale | -18% | $932,883 | $12.98 | -71,887 | 328,397 | 03 Mar 2026 | Direct |
| William F. Doyle | NVCR | Ordinary Shares | Award | 400,284 | 400,284 | 03 Mar 2026 | Direct | |||
| William F. Doyle | NVCR | Stock Option (Right to Buy) | Award | 288,517 | 288,517 | 03 Mar 2026 | Direct | |||
| Mukund Paravasthu | NVCR | Ordinary Shares | Sale | -0.53% | $5,505 | $13.49 | -408 | 76,343 | 02 Mar 2026 | Direct |
| Frank X. Leonard | NVCR | Ordinary Shares | Sale | -2.03% | $97,581 | $13.49 | -7,232 | 349,400 | 02 Mar 2026 | Direct |
| Ashley Cordova | NVCR | Ordinary Shares | Tax liability | -2.14% | -9,638 | 440,208 | 02 Mar 2026 | Direct | ||
| Uri Weinberg | NVCR | Ordinary Shares | Sale | -1.44% | $43,607 | $13.33 | -3,272 | 223,477 | 02 Mar 2026 | Direct |
| Frank X. Leonard | NVCR | Ordinary Shares | Award | 5.51% | 18,621 | 356,632 | 28 Feb 2026 | Direct | ||
| Ashley Cordova | NVCR | Ordinary Shares | Award | 5.59% | 23,818 | 449,846 | 28 Feb 2026 | Direct | ||
| Uri Weinberg | NVCR | Ordinary Shares | Award | 6.08% | 12,992 | 226,749 | 28 Feb 2026 | Direct | ||
| Barak Ben Arye | NVCR | Ordinary Shares | Award | 10.2% | 17,755 | 192,328 | 28 Feb 2026 | Direct | ||
| Mukund Paravasthu | NVCR | Ordinary Shares | Sale | -1.99% | $21,247 | $13.66 | -1,555 | 76,751 | 27 Feb 2026 | Direct |
| Nicolas Leupin | NVCR | Ordinary Shares | Sale | -0.98% | $14,060 | $13.66 | -1,029 | 104,079 | 27 Feb 2026 | Direct |
| Michal Nath Puri | NVCR | Ordinary Shares | Sale | -0.88% | $19,690 | $13.66 | -1,441 | 162,322 | 27 Feb 2026 | Direct |
| Frank X. Leonard | NVCR | Ordinary Shares | Sale | -2.8% | $133,003 | $13.66 | -9,734 | 338,011 | 27 Feb 2026 | Direct |
| Ashley Cordova | NVCR | Ordinary Shares | Tax liability | -2.64% | -11,541 | 426,028 | 27 Feb 2026 | Direct | ||
| Uri Weinberg | NVCR | Ordinary Shares | Sale | -3.37% | $103,257 | $13.84 | -7,461 | 213,757 | 27 Feb 2026 | Direct |
| Mukund Paravasthu | NVCR | Ordinary Shares | Tax liability | -2.65% | -2,133 | 78,306 | 11 Jan 2026 | Direct | ||
| Michal Nath Puri | NVCR | Ordinary Shares | Award | 1 | 163,763 | 31 Dec 2025 | Direct | |||
| Asaf Danziger | NVCR | Ordinary Shares | Award | 1 | 416,474 | 31 Dec 2025 | Direct | |||
| Barak Ben Arye | NVCR | Ordinary Shares | Award | 0.06% | 108 | 174,573 | 31 Dec 2025 | Direct | ||
| Christoph Brackmann | NVCR | Ordinary Shares | Tax liability | -4.98% | -7,033 | 134,117 | 04 Nov 2025 | Direct | ||
| Mukund Paravasthu | NVCR | Ordinary Shares | Tax liability | -3.54% | -2,949 | 80,439 | 04 Nov 2025 | Direct | ||
| Mukund Paravasthu | NVCR | Ordinary Shares | Tax liability | -0.2% | -168 | 83,388 | 01 Nov 2025 | Direct | ||
| Frank X. Leonard | NVCR | Ordinary Shares | Tax liability | -0.28% | -966 | 347,745 | 01 Nov 2025 | Direct | ||
| Michal Nath Puri | NVCR | Ordinary Shares | Tax liability | -0.46% | -752 | 163,762 | 31 Oct 2025 | Direct | ||
| Ashley Cordova | NVCR | Ordinary Shares | Purchase | 22.9% | $996,859 | $12.22 | 81,550 | 437,569 | 05 Sep 2025 | Direct |
| Christoph Brackmann | NVCR | Ordinary Shares | Purchase | 16.5% | $231,800 | $11.59 | 20,000 | 141,150 | 29 Jul 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.